PANCREATIC CANCER ACTION NETWORK RALLIES ADVOCATES FROM ALL 50 STATES TO URGE CONGRESS TO INCREASE FUNDING FOR PANCREATIC CANCER RESEARCH June 13, 2022 8:15 am|Increased Federal Funding Leads to Higher Pancreatic Cancer Survival Rates
Pulse survivors, mourners mark 6 years since massacre June 13, 2022 8:14 am|ORLANDO, Fla. (WFTV) – It’s not a landmark year, but that’s what many said is making it more…
Haitou Global Participates in the TCFA Seminar on the Outlook of Global Economy June 13, 2022 8:10 am|NEW YORK, June 13, 2022 /PRNewswire/ — Against the backdrop of rising inflation and global supply chain disruptions due…
Veoneer Demonstrates Latest Technologies and Scalable System Architecture at North American Ride & Drive June 13, 2022 8:08 am|SOUTHFIELD, Mich., June 13, 2022 /PRNewswire/ — The automotive technology company Veoneer is hosting a ride and drive…
Biotech Acquisition Company and Blade Therapeutics Mutually Agree to Terminate Business Combination Agreement June 13, 2022 8:06 am|NEW YORK and SOUTH SAN FRANCISCO, Calif., June 13, 2022 /PRNewswire/ — Biotech Acquisition Company (NASDAQ: BIOT) (“BAC”),…
QYOU Media India Expands its Digital Footprint Via One Plus on Smart TV's June 13, 2022 8:05 am|All Four Channels Currently Available Including The Q, Q Marathi, Q Kahaniyan and Q Comedistaan
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages IronNet, Inc. Investors to Secure Counsel Before Important June 21 Deadline in Securities Class Action – IRNT June 13, 2022 8:05 am|NEW YORK, June 13, 2022 /PRNewswire/ —
SURVIVEHER™ FOUNDER AND MULTIMEDIA PERSONALITY LYNDSAY LEVINGSTON SHARES HER POWERFUL STORY AS A BREAST CANCER SURVIVOR June 13, 2022 8:05 am|HOW GENETIC TESTING CAN PLAY A PIVOTAL ROLE IN BECOMING CANCER-FREE
Green Giant® Survey Reveals Broccoli As America's Favorite Vegetable in 2022 June 13, 2022 8:04 am|Fifth annual open-ended consumer survey finds the popular green continues to dominate the list of America’s favorite veggies
Enteris BioPharma Presents Data from Two Clinical Studies Involving Oral Formulations of Leuprolide at ENDO 2022 Annual Conference June 13, 2022 8:02 am|Data suggest that oral formulations of leuprolide developed utilizing Enteris’ Peptelligence® platform successfully deliver meaningful circulating drug concentrations…